<DOC>
	<DOCNO>NCT01746043</DOCNO>
	<brief_summary>The goal clinical research study compare armodafinil minocycline give alone combination learn good control side effect chemoradiation treatment esophageal cancer ( fatigue , pain , disturbed sleep , lack appetite , drowsiness ) . Armodafinil design prevent excessive sleepiness . Minocycline antibiotic , may help reduce multiple symptom . In study , may receive placebo . A placebo drug . It look like study drug design treat disease illness . It design compare study drug learn study drug real effect .</brief_summary>
	<brief_title>A Phase II Study Minocycline Armodafinil Reducing Symptom Burden Produced Chemoradiation Treatment Esophageal Cancer</brief_title>
	<detailed_description>Study Groups : If eligible take part study , randomly assign ( roll dice ) join 1 4 group . You equal chance group . - Group 1 take armodafinil placebo . - Group 2 take minocycline placebo . - Group 3 take armodafinil minocycline . - Group 4 take 2 placebo . Neither study staff see clinic know receive study drug ( ) and/or placebo ( ) . However , need safety , study staff able find study drug receiving . If need , give standard drug help decrease risk side effect . You may ask study staff information drug give risk . Study Drug/Placebo Administration : You take study drug/placebo 2 time day 6 week . You take capsule full glass water . If get upset stomach , take food . You give pamphlet information take study capsule . You bring study capsule every study visit . Completing Symptom Questionnaire : Throughout study , ask complete questionnaire symptom . This questionnaire ask symptom therapy may may interfere daily activity . The study staff either meet regular clinic visit call home time convenient . In clinic , complete questionnaire paper pen , enter answer electronic tablet computer . On phone , study staff member ask question record answer . You complete symptom questionnaire begin chemoradiation 1 time week rest study . The symptom questionnaire take 5 minute complete . Study Visits : Before begin chemoradiation : - You complete questionnaire pain symptom , mood , quality life . Completing 5 questionnaire take 15 minute . - If become pregnant pregnancy test screening , urine pregnancy test . The study staff give urine pregnancy test kit schedule visit , review result pick study capsule pharmacy . About Week 3 4 , ask complete questionnaire ask satisfaction study capsule . This take minute . During last week chemoradiation ( Week 5 6 ) : - You complete 3 questionnaire symptom , mood , quality life . These questionnaire take 10 minute total complete . - You also ask complete questionnaire ask satisfaction study capsule . This take minute . After Week 5 6 , study staff call 1 time week check study end . This phone call last minute . If several side effect chemoradiation , phone call may take long . At first routine clinical follow-up visit ( Week 10 14 ) : - You complete 3 questionnaire symptom , mood , quality life . - You also ask complete another questionnaire ask satisfaction study capsule . Length Study : You study 10-14 week . You take study drug ( ) 6 week complete symptom survey end study . You take study early intolerable side effect . This investigational study . Armodafinil FDA approve commercially available treatment sleepiness . Minocycline FDA approve commercially available treatment bacterial infection . The use drug help reduce chemoradiation symptom investigational . Up 80 patient take part study . All enrol MD Anderson .</detailed_description>
	<mesh_term>Esophageal Neoplasms</mesh_term>
	<mesh_term>Minocycline</mesh_term>
	<mesh_term>Armodafinil</mesh_term>
	<mesh_term>Modafinil</mesh_term>
	<criteria>1 . Patients pathologically proven diagnosis esophageal cancer 2 . Patients &gt; = 18 year old 3 . Patients receive chemotherapy radiation therapy 4 . Patients speak English Spanish 5 . Patients must willing able review , understand , provide write consent start therapy 6 . Patients must agree discontinue St John 's Wort herbal supplement use , refrain take protocol 7 . Women childbearing potential ( woman postmenopausal least 1 year surgically sterile ) must negative urine pregnancy test 8 . Sexually active male female must agree use effective birth control abstinent duration study period 9 . Women currently take birth control pills plan start birth control pill must agree additional method birth control ( either abstinence barrier method ) study medication 1 additional month study completion . 1 . Patients enrol symptom management clinical trial 2 . Patients currently take methylphenidate and/or dextroamphetamine 3 . Patients history clinically significant cutaneous drug reaction , history clinically significant hypersensitivity reaction , document patient medical record 4 . Patients preexist psychosis bipolar disorder 5 . Patients preexist renal impairment : The screening cut serum creatinine &gt; 1.5 time upper limit normal , within past 30 day , do oncologist qualify CXRT . 6 . Patients preexist hepatic impairment : The screening total bilirubin &gt; 25.7 Âµmol/L ( 1.5 mg/dL ) do oncologist qualify CXRT . The screen &gt; 2 time upper limit normal hepatotoxicity , alkaline phosphatase ( ALP ) , alanine aminotransferase ( ALT ) aspartate aminotransferase ( AST ) do oncologist qualify CXRT . 7 . Patients preexist Tourette 's syndrome 8 . Patients hypersensitivity tetracyclines 9 . Patients uncontrolled cardiac disease , include angina cardiac ischemia , leave ventricular hypertrophy , myocardial infarction , mitral valve prolapse . 10 . Patients take medicine strong CYP3A4 inhibitor inducer ( include conivaptan , indinavir , nelfinavir , ritonavir , nefazodone , phenetoin ) , strong CYP2C19 inhibitor ( include citalopram clopidogrel ) . 11 . Patients vitamin K antagonist warfarin</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2017</verification_date>
	<keyword>Esophageal cancer</keyword>
	<keyword>Chemotherapy</keyword>
	<keyword>Radiation therapy</keyword>
	<keyword>XRT</keyword>
	<keyword>Chemoradiation</keyword>
	<keyword>CXRT</keyword>
	<keyword>Symptom Burden</keyword>
	<keyword>Armodafinil</keyword>
	<keyword>Nuvigil</keyword>
	<keyword>Minocycline</keyword>
	<keyword>Dynacin</keyword>
	<keyword>Minocin</keyword>
	<keyword>Minocin PAC</keyword>
	<keyword>Myrac</keyword>
	<keyword>Solodyn</keyword>
	<keyword>Placebo</keyword>
	<keyword>Sugar pill</keyword>
	<keyword>Questionnaires</keyword>
	<keyword>Surveys</keyword>
</DOC>